Viability and apoptosis measured by imaging in BRAF(V600E/D) melanoma cell lines following treatment with combinations of three compounds (viability/apoptosis dataset 2 of 2) - Dataset (ID:20273)

Filter results: >>>>
Cell Small Molecule 1 Small Molecule 2 Small Molecule 3 Small Mol 1 Concentration Small Mol 2 Concentration Small Mol 3 Concentration Small Mol Conc Unit Time Point Time Point Unit Replicate Total Number of Cells (Nuclei) Number of Apoptotic Cells Relative Viability Mean Relative Viability Apoptosis Fraction Mean Apoptosis Fraction
WM-115 Vemurafenib Trametinib Defactinib 0.0000 0.0000 1.0000
uM
72
hr
3 2655 180 0.6416 0.6483 0.0678 0.0808
WM-115 Vemurafenib Trametinib Defactinib 0.0000 0.0000 1.0000
uM
72
hr
2 2729 242 0.6447 0.6483 0.0887 0.0808
WM-115 Vemurafenib Trametinib Defactinib 0.0000 0.0000 1.0000
uM
72
hr
1 2779 239 0.6585 0.6483 0.0860 0.0808
WM-115 Vemurafenib Trametinib Defactinib 0.0000 0.0000 0.3160
uM
72
hr
3 3633 273 0.8711 0.8287 0.0751 0.0771
WM-115 Vemurafenib Trametinib Defactinib 0.0000 0.0000 0.3160
uM
72
hr
2 3395 272 0.8096 0.8287 0.0801 0.0771
WM-115 Vemurafenib Trametinib Defactinib 0.0000 0.0000 0.3160
uM
72
hr
1 3363 256 0.8055 0.8287 0.0761 0.0771
WM-115 Vemurafenib Trametinib Defactinib 0.0000 0.0000 0.0000
uM
72
hr
3 4017 228 0.9823 1.0000 0.0568 0.0590
WM-115 Vemurafenib Trametinib Defactinib 0.0000 0.0000 0.0000
uM
72
hr
2 4322 279 1.0481 1.0000 0.0646 0.0590
WM-115 Vemurafenib Trametinib Defactinib 0.0000 0.0000 0.0000
uM
72
hr
1 3961 221 0.9696 1.0000 0.0558 0.0590
WM-115 Vemurafenib Trametinib Dasatinib 3.1600 0.3160 3.1600
uM
72
hr
3 937 801 0.0319 0.0294 0.8549 0.8675